InsiderTrades

Form 4 for IDXX Idexx Laboratories

Accepted 2026-02-17 00:00:00 ET · period of report 2026-02-12 · accession 0000874716-26-000021 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-02-17 2026-02-14 IDXX Hunt Nimrata EVP F - Tax $629.35 -1,154 22.6K -5% -$726.3K
DM 2026-02-17 2026-02-14 IDXX Hunt Nimrata EVP M - OptEx $0.00 +2,587 21.6K +14% $0
DM 2026-02-17 2026-02-14 IDXX Hunt Nimrata EVP M - OptEx $0.00 -2,587 602 -81% $0
DM 2026-02-17 2026-02-12 IDXX Hunt Nimrata EVP A - Grant $0.00 +7,501 1,620 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-14 F D 1,154 $629.35 22,591.94 D — — (F2) Closing price of Issuer common stock on Nasdaq Global Select Market on February 13, 2026.
2 Common Common Stock 2026-02-14 M A 367 $0.00 23,745.94 D — —
3 Common Common Stock 2026-02-14 M A 1,508 $0.00 23,378.94 D — —
4 Common Common Stock 2026-02-14 M A 301 $0.00 21,870.94 D — —
5 Common Common Stock 2026-02-14 M A 204 $0.00 21,362.94 D — — (F1) 1. Includes 10 shares purchased under the Issuer Employee Stock Purchase Plan ('ESPP') on December 31, 2025. There are a total of 401.944 shares held in the ESPP which has been increased by 0.005 shares due to a rounding calculation of previously issued fractional shares.
6 Common Common Stock 2026-02-14 M A 207 $0.00 21,569.94 D — —
7 Derivative Restricted Stock Unit 2026-02-14 M D 367 $0.00 1,101 D — · — to — 367 Common Stock (F10) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2026.
8 Derivative Incentive Stock Option (right-to-buy) 2026-02-12 A A 162 $0.00 162 D $617.20 · — to 2036-02-11 162 Common Stock (F4) Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030.
9 Derivative Non-Qualified Stock Option (right-to-buy) 2026-02-12 A A 4,625 $0.00 4,625 D $617.20 · — to 2036-02-11 4,625 Common Stock (F3) Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027.
10 Derivative Restricted Stock Unit 2026-02-14 M D 1,508 $0.00 0 D — · — to — 1,508 Common Stock (F11) Each RSU represents a contingent right to receive one share of Issuer common stock and vested in one installment on February 14, 2026.
11 Derivative Restricted Stock Unit 2026-02-12 A A 1,094 $0.00 1,094 D — · — to — 1,094 Common Stock (F5) Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock that vests in four annual installments, beginning February 14, 2027.
12 Derivative Restricted Stock Unit 2026-02-12 A A 1,620 $0.00 1,620 D — · — to — 1,620 Common Stock (F6) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in three annual installments, beginning February 14, 2027.
13 Derivative Restricted Stock Unit 2026-02-14 M D 204 $0.00 0 D — · — to — 204 Common Stock (F7) Each RSU represents a contingent right to receive one share of Issuer common stock that vested in four annual installments, beginning February 14, 2023.
14 Derivative Restricted Stock Unit 2026-02-14 M D 207 $0.00 207 D — · — to — 207 Common Stock (F8) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024.
15 Derivative Restricted Stock Unit 2026-02-14 M D 301 $0.00 602 D — · — to — 301 Common Stock (F9) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025.